AIM ImmunoTech (NYSE:AIM) Sees Large Volume Increase

Share on StockTwits

Shares of AIM ImmunoTech Inc. (NYSE:AIM) saw unusually-strong trading volume on Monday . Approximately 3,384,999 shares traded hands during trading, an increase of 1,284% from the previous session’s volume of 244,655 shares.The stock last traded at $0.46 and had previously closed at $0.40.

Separately, Maxim Group raised shares of AIM ImmunoTech from a “hold” rating to a “buy” rating in a research report on Thursday, October 10th.

The company’s 50-day moving average price is $0.49. The company has a debt-to-equity ratio of 0.33, a current ratio of 3.01 and a quick ratio of 3.01.

An institutional investor recently bought a new position in AIM ImmunoTech stock. Sabby Management LLC purchased a new position in AIM ImmunoTech Inc. (NYSE:AIM) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 185,171 shares of the company’s stock, valued at approximately $141,000. Sabby Management LLC owned 2.24% of AIM ImmunoTech at the end of the most recent reporting period. 41.19% of the stock is owned by institutional investors.

About AIM ImmunoTech (NYSE:AIM)

AIM ImmunoTech Inc, an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).

Further Reading: What are benefits of a growth and income fund?

Receive News & Ratings for AIM ImmunoTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIM ImmunoTech and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Horizen Trading Down 2.1% Over Last Week
Horizen Trading Down 2.1% Over Last Week
ELTCOIN Price Up 15.1% Over Last Week
ELTCOIN Price Up 15.1% Over Last Week
RealTract Price Reaches $0.0010 on Major Exchanges
RealTract Price Reaches $0.0010 on Major Exchanges
V-ID Price Hits $0.0737 on Exchanges
V-ID Price Hits $0.0737 on Exchanges
Brokerages Expect Meridian Bioscience, Inc.  Will Announce Quarterly Sales of $48.90 Million
Brokerages Expect Meridian Bioscience, Inc. Will Announce Quarterly Sales of $48.90 Million
Zacks: Brokerages Expect Stantec Inc.  Will Post Earnings of $0.34 Per Share
Zacks: Brokerages Expect Stantec Inc. Will Post Earnings of $0.34 Per Share


© 2006-2019 Ticker Report